RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 92 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $26,250 | -59.6% | 150,000 | 0.0% | 0.00% | – |
| Q3 2022 | $65,000 | -49.2% | 150,000 | 0.0% | 0.00% | – |
| Q2 2022 | $128,000 | -12.9% | 150,000 | +460.4% | 0.00% | – |
| Q1 2022 | $147,000 | -69.9% | 26,766 | -47.0% | 0.00% | – |
| Q4 2021 | $489,000 | -46.9% | 50,514 | -2.0% | 0.00% | – |
| Q3 2021 | $921,000 | -23.6% | 51,542 | +4.4% | 0.00% | -100.0% |
| Q2 2021 | $1,205,000 | +2.6% | 49,390 | +11.3% | 0.00% | 0.0% |
| Q1 2021 | $1,175,000 | +225.5% | 44,360 | -6.8% | 0.00% | – |
| Q4 2020 | $361,000 | +75.2% | 47,602 | +15.5% | 0.00% | – |
| Q3 2020 | $206,000 | +83.9% | 41,222 | +120.7% | 0.00% | – |
| Q2 2020 | $112,000 | +100.0% | 18,676 | +48.0% | 0.00% | – |
| Q1 2020 | $56,000 | -77.1% | 12,619 | -51.3% | 0.00% | – |
| Q4 2019 | $245,000 | +81.5% | 25,917 | +49.4% | 0.00% | – |
| Q3 2019 | $135,000 | -63.2% | 17,344 | -26.2% | 0.00% | – |
| Q2 2019 | $367,000 | -46.7% | 23,507 | -38.5% | 0.00% | – |
| Q1 2019 | $689,000 | +418.0% | 38,214 | +356.3% | 0.00% | – |
| Q4 2018 | $133,000 | -89.3% | 8,374 | -83.9% | 0.00% | – |
| Q3 2018 | $1,245,000 | – | 51,918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |